Birmingham, West Midlands -- (SBWIRE) -- 12/26/2013 -- Value Penny Stocks issues special report on Avanir Pharmaceuticals Inc (NASDAQ:AVNR), EarthLink, Inc. (NASDAQ:ELNK), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), Bioanalytical Systems, Inc. (NASDAQ:BASI).
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) opened its last trade at the price of $3.43. Its closing price was $3.33 after losing -2.06% for the day. The company traded with the total volume of 999,717 shares, while its average trading volume remained 3.08 million shares. The beta of this stock stands at 1.38. Avanir Pharmaceuticals, Inc., together with its subsidiaries, is engaged in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States.
Has AVNR Found The Bottom and Ready To Move Up? Find Out Here
EarthLink, Inc. (NASDAQ:ELNK) percentage change plunged -1.58% to close at $4.98 with the total traded volume of 992,576 shares, along with average volume of 814,061.00 shares. The 52 week range of the stock remained $4.70 - $7.07, while its day lowest price was $4.90. The share price hit the day highest price of $5.11. EarthLink, Inc. provides network, communications, and IT services in the United States. The company operates in two segments, Business Services and Consumer Services. The Business Services segment offers high-speed and dedicated Internet access, and multiprotocol label switching services; switched access, long distance services.
Has ELNK Found The Bottom And Ready To Gain Momentum? Find Out Here
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) traded on volume of 982,366 shares in the last session against average volume of 2.39 million shares. The company started its trading session with the price of $3.50 and closed at $3.39. Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. It focuses on the development of antivirals for the treatment of chronic hepatitis C viral (HCV) infection.
How Should Investors Trade ACHN Now? Don’t Miss out a Special Trend Analysis
Bioanalytical Systems, Inc. (NASDAQ:BASI) started its last trading session with the price of $3.00 and closed at $3.06. The stock traded with total volume of 979,624 shares, while the average trading volume remained 28,666.00 shares. The beta value of this stock stands at 2.27. Day range for the stock was $2.75 - $3.80. Bioanalytical Systems, Inc. provides drug discovery and development services for pharmaceutical, biotechnology, academic, and government organizations in North America, the Pacific Rim, Europe, and internationally. It operates in two segments, Contract Research Services and Research Products.
What BASI’s Charts Are Signaling for Traders? Find Out Here
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)